HCG acquires SRJ CBCC Cancer Hospital in Indore

Healthcare Global Enterprises Limited (HCG), the largest cancer care network in India, today announced the strategic acquisition of SRJ CBCC Cancer hospital in Indore. This acquisition marks HCG's entry into the key geography of Madhya Pradesh enhancing its commitment to delivering world-class cancer care across India. HCG further plans to expand by adding 100 beds and state of art cancer diagnostic and treatment facility within an estimated operational timeline of 2 years, demonstrating a commitment to meeting the region's healthcare demands. With its entry into the 10th state, HCG is now a network of 21 comprehensive cancer centers with 24 hospitals across India and Africa, and 8 Daycare centres.

SRJ CBCC Cancer Hospital is centrally located and is the city's first comprehensive cancer Centre and is currently the market leader in private space. The hospital has 50 Cancer Care beds and houses state-of-the-art LINAC machine. The acquisition also unlocks opportunities for operational scale-up, including the introduction of organ-specific practices and the introduction of next-gen cancer care technologies.

Dr. B. S. Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited, said, "This milestone marks our entry into this vibrant healthcare market and underscores our unwavering commitment to delivering world-class cancer care. We believe in the potential of this acquisition to make a meaningful impact on the lives of countless patients and further our mission of ensuring accessible and exceptional cancer care across India. Our team's commitment and SRJ CBCC Cancer Hospital's established tradition of excellence make us ready to revolutionize oncology care in Indore and the surrounding areas."

Speaking at the occasion, Mr. Raj Gore, CEO, Healthcare Global Enterprises Limited, said, "We are thrilled to extend our presence in Madhya Pradesh, the heart of Incredible India. Entering Indore, we aim to find more opportunities to address the critical gap in cancer care in Madhya Pradesh. Our endeavor is to make the most advanced and comprehensive cancer treatment available to patients and provide longer and better quality of life to each patient without having to travel miles for it. We would be extending our network strength of renowned oncologists' and largest Tumor Board in the country to Indore and Madhya Pradesh. Patient outcome is of paramount importance to us and we ensure that all our clinical and non-clinical resources are channelized and geared towards patient care."

India faces a significant challenge of a large cancer incidence burden which continues to grow further. Madhya Pradesh accounts for sizable share of cancer incidence in India with high prevalence of Head & Neck and Tongue cancer in Men and Breast and Cervix cancer in women.

HCG has been in pursuit of cancer diagnostic and treatment since 1989, it set up its first Cancer Centre in Bangalore. All the 21 cancer centers of HCG provide comprehensive diagnostic and treatment facilities. Recognized for innovative treatment protocols, cutting-edge diagnostic and treatment technology, and exceptional patient outcomes, HCG has provided exemplary care to millions of patients since its inception. Patients benefit from a multi-disciplinary approach to cancer care, spanning prevention, screening, second opinions, diagnosis, treatment, rehabilitation, and palliative or supportive care. With this HCG is set to revolutionize cancer treatment for cancer patients in Indore.

Shares of Healthcare Global Enterprises Limited was last trading in BSE at Rs. 362.60 as compared to the previous close of Rs. 358.90. The total number of shares traded during the day was 6937 in over 497 trades.

The stock hit an intraday high of Rs. 363.80 and intraday low of 353.00. The net turnover during the day was Rs. 2491400.00.

Source : Equity Bulls

Keywords

HealthcareGlobalEnterprises INE075I01017 HCG HealthcareFacilities Acquisition SRJCBCC CancerHospital Indore